Single-dose HPV vaccine immunity: is there a role for non-neutralizing antibodies?
A single dose of human papillomavirus (HPV) vaccine against HPV infection (prerequisite
for cervical cancer) appears to be as efficacious as two or three doses, despite inducing …
for cervical cancer) appears to be as efficacious as two or three doses, despite inducing …
HPV vaccines: translating immunogenicity into efficacy
TB Turner, WK Huh - Human vaccines & immunotherapeutics, 2016 - Taylor & Francis
Currently available human papillomavirus (HPV) vaccines are very successful at preventing
persistent HPV infection and premalignant cervical lesions. In part due to the unique aspects …
persistent HPV infection and premalignant cervical lesions. In part due to the unique aspects …
HPV-immune response to infection and vaccination
M Stanley - Infectious agents and cancer, 2010 - Springer
HPV infection in the genital tract is common in young sexually active individuals, the majority
of whom clear the infection without overt clinical disease. However most of those who …
of whom clear the infection without overt clinical disease. However most of those who …
Cross-Reactivity, Epitope Spreading, and De Novo Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) …
M Nakagawa, W Greenfield… - Clinical and Vaccine …, 2015 - Am Soc Microbiol
Numerous versions of human papillomavirus (HPV) therapeutic vaccines designed to treat
individuals with established HPV infection, including those with cervical intraepithelial …
individuals with established HPV infection, including those with cervical intraepithelial …
current knowledge on the role of HPV antibodies after natural infection and vaccination: implications for monitoring an HPV vaccination programme
M Mollers, JM Vossen, M Scherpenisse… - Journal of medical …, 2013 - Wiley Online Library
Abstract In 2006/2007, two vaccines were licensed against two of the most common HPV
types that cause about 70% of cervical cancers. Clinical trials show that vaccinated …
types that cause about 70% of cervical cancers. Clinical trials show that vaccinated …
Prevention and treatment of papillomavirus-related cancers through immunization
IH Frazer, GR Leggatt… - Annual review of …, 2011 - annualreviews.org
Cervical and other anogenital cancers are initiated by infection with one of a small group of
human papillomaviruses (HPV). Virus-like particle-based vaccines have recently been …
human papillomaviruses (HPV). Virus-like particle-based vaccines have recently been …
HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection
TJ Kemp, A Hildesheim, M Safaeian, JG Dauner, Y Pan… - Vaccine, 2011 - Elsevier
Human papillomavirus (HPV) L1 VLP-based vaccines are protective against HPV vaccine-
related types; however, the correlates of protection have not been defined. We observed that …
related types; however, the correlates of protection have not been defined. We observed that …
Human papillomavirus-specific immune therapy: failure and hope
K Nieto, L Gissmann, L Schädlich - Antiviral therapy, 2010 - journals.sagepub.com
Recently, two prophylactic vaccines against the most significant oncogenic human
papillomaviruses (HPV; 16 and 18) became available that efficiently protect against …
papillomaviruses (HPV; 16 and 18) became available that efficiently protect against …
HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future
L Mariani, A Venuti - Journal of translational medicine, 2010 - Springer
Although long-term protection is a key-point in evaluating HPV-vaccine over time, there is
currently inadequate information on the duration of HPV vaccine-induced immunity and on …
currently inadequate information on the duration of HPV vaccine-induced immunity and on …
Human papillomavirus vaccines–immune responses
M Stanley, LA Pinto, C Trimble - Vaccine, 2012 - Elsevier
Prophylactic human papillomavirus (HPV) virus-like particle (VLP) vaccines are highly
effective. The available evidence suggests that neutralising antibody is the mechanism of …
effective. The available evidence suggests that neutralising antibody is the mechanism of …